West Pharma falls as 2025 profit, revenue forecast below estimates

West Pharmaceutical Services

13/02/2025 16:33

(Updates)
    ** Shares of medical equipment maker West Pharmaceutical
Services  WST.N  fall as much as 31.7% to an over-two-year low
of $220
    ** Co sees 2025 adj profit between $6 and $6.20 per share,
missing analysts avg estimate of $7.44 per share - LSEG 
    ** Sees 2025 sales between $2.88 bln and $2.91 bln, below
estimates of $3.04 bln 
    ** Posts Q4 adj profit of $1.82 per share vs analysts avg
estimate of $1.72 per share
    ** Posts Q4 sales of $748.8 mln vs analysts avg estimate of
$740.47 mln 
    ** In the last 12 months, WST has fallen ~21%

 (Reporting by Siddhi Mahatole)
 ((Siddhiprabhanjan.mahatole@thomsonreuters.com))